Dr. Edward Yen, a medical oncologist at Baylor College of Medicine in Houston, explains how radioligand therapy works and who is eligible.
Facing advanced prostate cancer can be a daunting process that brings out many questions and concerns — but it’s important to understand that there are still many treatment options available.
An innovative new approach is something called radioligand therapy. Here, Dr. Edward Yen, medical oncologist at Baylor College of Medicine in Houston, explains how the treatment works and who is eligible.
Content independently created by SurvivorNet with support from Novartis Pharmaceuticals Corp.
Dr. Edward Yen
Baylor College of Medicine
Every prostate cancer journey begins with a clear understanding of the diagnosis. This isn't a "one-size-fits-all" disease, and treatment plans are highly personalized.
Sign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.
